Date	Name	Title	Type	Shares Traded	Price Range
Oct 29, 2008	bloch stephen m	Director	Automatic Sell	3,000	8.51
Oct 28, 2008	bloch stephen m	Director	Automatic Sell	2,601	8.50
Nov 28, 2008	bloch stephen m	Director	Automatic Sell	3,000	8.50
Nov 21, 2008	bloch stephen m	Director	Automatic Sell	2,436	8.50
Dec 2, 2008	bloch stephen m	Director	Automatic Sell	1,544	8.50
Dec 3, 2008	bloch stephen m	Director	Automatic Sell	25	8.50
Mar 1, 2009	dentzer james e	Officer	Disposition (Non Open Market)	220	8.06
Jan 2, 2009	dentzer james e	Officer	Disposition (Non Open Market)	220	8.00
Dec 1, 2008	dentzer james e	Officer	Disposition (Non Open Market)	220	7.98
May 24, 2011	valenzano ken	Officer	Sell	2,250	7.50
Jun 1, 2009	dentzer james e	Officer	Disposition (Non Open Market)	220	6.64
Jun 5, 2007	barkas alexander e	Director	Option Execute	15,119	6.38
Jun 5, 2007	barris peter j	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	kramlich c richard	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	new enterprise associates 11 lp	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	newhall charles w iii	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	perry mark w	Beneficial Owner (10% or more)	Option Execute	15,077	6.38
Jun 5, 2007	prospect venture partners ii lp	Beneficial Owner (10% or more)	Option Execute	15,119	6.38
Jul 17, 2012	glaxosmithkline plc	Beneficial Owner (10% or more)	Buy	2,949,581	6.30
Jun 17, 2011	crowley john f	Officer	Buy	20,000	6.04
Showing 301-320 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.